A carregar...

A 52-Week, Double-Blind Evaluation of the Metabolic Effects of Aripiprazole and Lithium in Bipolar I Disorder

Introduction: Metabolic risk factors, termed metabolic syndrome, which include obesity, diabetes, dyslipidemia, and hypertension, are more common in patients with bipolar disorder than in the general population. Moreover, medications used to treat bipolar disorder carry some risk of worsening metabo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: McIntyre, Roger S., McElroy, Susan L., Eudicone, James M., Forbes, Robert A., Carlson, Berit X., Baker, Ross A.
Formato: Artigo
Idioma:Inglês
Publicado em: Physicians Postgraduate Press, Inc. 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3304683/
https://ncbi.nlm.nih.gov/pubmed/22454801
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/PCC.11m01182
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!